[Brief Introduction of Seminar]

Vascular health is no longer limited to improving blood circulation. Increasingly, effective vascular care requires addressing both vascular occlusion caused by blood clots and vascular stiffness resulting from arterial calcification.

This seminar will explore these two key aspects of vascular health—"Blocked Blood Vessels" and "Hardened Blood Vessels"—by reviewing the mechanisms of action and the latest scientific research on Nattokinase and Vitamin K2. We will also introduce an innovative solution for vascular and bone health by combining these two functional ingredients.

In addition, GF Fermentech will present its proprietary fermentation technology and high-quality vegan ingredients, highlighting their superior stability and quality competitiveness. The seminar will also discuss practical strategies for applying these ingredients to the development of differentiated health functional food products and creating added value in the marketplace.

[Brief Introduction of Speaker]

Mr. Bok-Jun Park, Team Leader of the Sales & Marketing Team at GF Fermentech, holds a Master's degree in Biotechnology and has over 20 years of experience in the food, nutraceutical, and cosmetic ingredient industries. Throughout his career, he has specialized in the research, technical sales, and marketing of functional ingredients.

He has worked extensively with a wide range of microbial fermentation-based functional ingredients, including amino acids, yeast, DHA, chlorella, astaxanthin, and GABA. His experience spans technical support, B2B sales and marketing, and assisting customers throughout the entire product development process—from ingredient selection and product planning to market application.

Currently, at GF Fermentech, Mr. Park is responsible for the B2B sales and marketing of fermentation-based functional ingredients, with a particular focus on Vitamin K2 and Nattokinase. Leveraging scientific evidence and extensive industry expertise, he provides differentiated ingredient solutions for vascular and bone health.​ 

[Brief Introduction of Seminar] 

A National Treasure "Antrodia cinnamomea" in Taiwan: Revolutionary Technology to Cultivate its Mycelium & R&D for Hepatoprotection and Immunomodulation

Taiwan's legendary 'Forest Ruby' - from traditional remedy to global clinical evidence

Antrodia cinnamomea (niu-chang-chih) is a rare medicinal fungus endemic to Taiwan, growing exclusively on the heartwood of the endangered Cinnamomum kanehirae tree. Known as the "Forest Ruby" for its brilliant red fruiting body, it has been revered in traditional medicine for centuries for hepatoprotection, anti-inflammation, detoxification, hangover relief, and immune enhancement. Wild harvesting has led to near-extinction of natural resources, and the tree species is now legally protected. Antromax® overcomes this supply challenge through solid-state cultivation while delivering superior active compound profiles compared to wild material, enabling standardized, scalable, and sustainable production for global commercial application.

PATENTED FERMENTATION TECHNOLOGY

Greenyn's proprietary adversity-domestication fermentation platform is the technological breakthrough. Unlike conventional liquid fermentation (minimal triterpenoids) or log-cultivation (2-3 years, unsustainable), this platform simulates the fungus's native habitat stress conditions - controlled temperature, humidity, pH, and nutritional stress - triggering robust secondary metabolite production.

Key Metrics: Total triterpenoids exceed 180% of 3-year-old wild fruiting bodies.

Cultivation Cycle: 3-4 months vs. 2-3 years wild.

8-Country Patent Family: Taiwan (1543706), USA (US9458421B2), Germany, Japan (5814322/3188254), China (ZL201310432728.7), Malaysia (MY167124A), Korea (10-2125300), and Belgium.

STRONG CLINICAL EVIDENCE & FUNCTIONAL BENEFITS

Hepatoprotection (RCT, Japan): Double-blind, placebo-controlled 12-week trial in 38 sub-healthy adults (ALT 30-51 IU/L) demonstrated significant ALT/AST reduction.

Chronic Hepatitis B (RCT, China Medical University Hospital): Adjuvant therapy to Entecavir showed enhanced viral suppression and liver enzyme normalization.

Alcohol Metabolism: Animal studies showed ADH +40%, ALDH +42%, accelerating sobriety by 7 hours.

Safety Profile: Passed acute toxicity (NOAEL), 90-day sub-chronic, genotoxicity testing (Ames negative), and teratogenicity testing.

Global Compliance & Certifications: USFDA NDI No. 1170 (world's first), health food certification, SNQ National Quality Mark, ISO 22000, FSSC 22000, GMP, and Halal.

​[Brief Introduction of Speaker] 

Dr. Leon Hsu

CEO & R&D Director, Greenyn Biotechnology (TPEx: 6846)

EDUCATION

Ph.D. in Food Science and Biotechnology, National Chung Hsing University, Taiwan

Cross-disciplinary training in molecular biology, food chemistry, and nutraceutical product development  

EXPERIENCE

CEO & R&D Director, Greenyn Biotechnology (Listed on TPEx: 6846) - leading 150+ professionals

Transitioned Greenyn from ingredient distributor into a science-driven, publicly listed global innovator exporting to 15+ countries

Full-spectrum R&D pipeline: functional peptide engineering, solid-state fermentation, clinical trials, international regulatory submissions (FDA, EFSA, Japan, Korea, China)

KEY ACHIEVEMENTS

Invented 10+ proprietary branded ingredients including Insumate (patented bitter melon peptide for blood sugar management), Antromax (world's first FDA NDI Antrodia cinnamomea), Citrusvel and more across metabolic health, hepatoprotection, immunity, and immune health etc.

100+ international patents across 8 countries (US, EU, JP, CN, KR, MY, TW, DE) for functional ingredient compositions, fermentation technologies, and peptide sequences

Published 10+ peer-reviewed international journal papers on functional peptide discovery, clinical validation, and bioactive compound characterization

Awarded 30+ international invention prizes, and National Innovation Award and multiple domestic invention honors

Achieved 2 USFDA-NDI, Received 2 SNQ National Quality Marks, multiple health food functional claims (liver function and immune health), and spearheaded Greenyn's IPO (TPEx: 6846) 

[Brief Introduction of Seminar]

Sucrosomial® Technology represents a breakthrough in nutrient absorption.

This innovative approach was born from the need to enhance nutrient uptake while minimizing digestive issues often associated with traditional supplements.

Pharmanutra engineered Sucrosomial® coating to shield nutrient particles from harsh stomach acids and enzymes, ensuring their safe passage through the digestive tract.

The efficacy of Sucrosomial® Technology isn't just theoretical but supported by scientific research.

For anyone seeking to optimize their nutrient intake, this technology promises better absorption and a more comfortable and effective supplementation experience overall.

[Brief Introduction of Speaker]

Completing studies in business administration and working for several years in the banking industry.

Joined Pharmanutra in 2002, having the opportunity to significantly contribute to the Pisa-based company's rapid growth. 

Shareholder since the first day of the company's listing of 2017 and Senior Operations Manager with over 20 years of experience in the nutraceutical industry in Italy.​ 

[Brief Introduction of Seminar]

The health and nutrition industry is entering a new phase of innovation, driven by the rise of GLP-1, growing awareness of women’s health needs across life stages, and increasing interest in healthy aging. As consumer needs continue to evolve, it is becoming increasingly important for dietary supplements and nutrition solutions to be grounded in science and translated into meaningful health support.

In this session, Dr. Kai Lin Ek, Head of Scientific & External Affairs, APAC at dsm-firmenich, will share the latest nutrition science insights and innovation opportunities across three key areas: GLP-1, women’s health, and healthy aging. The presentation will explore emerging nutrition needs in the GLP-1 era and discuss how nutrition science can help shape solutions that respond to evolving health priorities.

The session will also highlight women’s health needs across different life stages and discuss targeted nutrition approaches to support these evolving needs. In addition, Dr. Ek will introduce scientific evidence related to healthy aging, including insights from the DO-HEALTH study, one of Europe’s largest healthy aging studies, and discuss how integrated nutrition solutions can support GLP-1, women’s health, and long-term wellbeing.

[Brief Introduction of Speaker]

Dr. Kai Lin EK is Head of Scientific and External Affairs APAC for Health, Nutrition & Care at dsm-firmenich. She has a Ph.D. in human nutrition and food science and a Master’s in nutrition and dietetics from the University of Sydney, Australia.

At dsm-firmenich, Kai Lin is responsible for providing science-based evidence for the health and nutrition portfolio and leads nutrition research collaborations in APAC. She works closely with the dsm-firmenich global expert team to bring scientific messages into regionally fit health claims and in advancing advocacy needs in Asia-Pacific.

Kai Lin has 18 years of experience in the field of human nutrition, starting as an accredited practicing dietitian in Sydney in primary health care, then as research manager at the Sydney University glycemic index services before moving to Singapore to work in the nutrition industry. She has a good understanding of conducting nutrition research in APAC having spearheaded and led a research grant program which studied nutritional topics relevant for Asian demographics and diets which she is replicating again with the dsm-firmenich Nutrition Research Grant program. She has also previously led a regulatory affairs team in APAC where she used her scientific expertise to help shape regulations in the region and support health claims.​ 

[Brief Introduction of Seminar]

The dietary supplements market is evolving rapidly as consumers take a more proactive approach to health and wellbeing. Across global markets, growing concerns around healthy aging, preventive health, immunity, mental wellbeing, and quality of life are reshaping consumer expectations and influencing purchasing decisions.

In this session, Ng Hock Yam, APAC Dietary Supplements Segment Lead at dsm-firmenich, will share key insights from recent consumer research and global market trends. Drawing on perspectives from multiple markets across Asia Pacific and beyond, he will explore how consumer health concerns are changing across different life stages and how these shifts are creating new opportunities for innovation in the dietary supplements industry.

The session will examine the key consumer and market trends shaping the future of dietary supplements, and how these trends are supporting the growing focus on healthy longevity.

[Brief Introduction of Speaker]

Ng Hock Yam is the Dietary Supplements Segment Lead for Asia Pacific (APAC) within the Health, Nutrition & Care business at dsm-firmenich.

With more than 20 years of experience in the consumer packaged goods (CPG) industry, he has built extensive expertise in sales and marketing through local, regional, and global roles at leading multinational companies including Nokia, McDonald's, and Nestlé. Throughout his career, he has developed strong customer-centric capabilities, developing and commercializing insights based growth strategy.

In his current role, Hock Yam leads growth and innovation strategies for the dietary supplements market across APAC. He works closely with customers to support business growth and product innovation through differentiated, science-based solutions that address evolving consumer and market needs.​

[Brief Introduction of Seminar]

Taste is one of the key factors influencing patient experience, product acceptance, and medication adherence. However, pharmaceutical formulators often face significant challenges when working with bitter or unpleasant-tasting active ingredients, particularly in oral dosage forms.

In this session, Shermaine Lee, APAC Pharma Segment Lead at dsm-firmenich, will introduce how dsm-firmenich’s Pharma Taste Collection and BitterBlockers™ technology can help address taste-related formulation challenges in pharmaceutical products. Through practical examples from oral solid and liquid dosage forms, the session will explore effective taste optimization strategies that improve patient experience, enhance product acceptance, and support better adherence outcomes.

[Brief Introduction of Speaker]

Shermaine Lee is Associate Director, APAC Pharma Segment Lead at dsm-firmenich Health, Nutrition & Care, where she leads the pharmaceutical business strategy across Asia Pacific. With over 15 years of experience spanning pharmaceuticals, consumer health, and FMCG, she has also held regional and local leadership roles at Kenvue (formerly Johnson & Johnson Consumer Health), Nestlé, and iNova Pharmaceuticals.

Throughout her career, Shermaine has managed regional portfolios across APAC, AMENA, and global markets, driving growth through innovation, portfolio strategy, go-to-market excellence, and customer partnerships. Her expertise spans pharmaceutical ingredients, excipients, consumer health brands, and healthcare marketing, with a strong focus on translating market insights into commercial opportunities.

At CPHI Korea, Shermaine will share how dsm-firmenich's Pharma Taste Collection and BitterBlockers™ technology help pharmaceutical and nutraceutical companies overcome taste-related formulation challenges. The session will explore strategies to improve patient experience, acceptance, and adherence through effective taste optimization, with practical examples from oral solid and liquid dosage forms.​

[Brief Introduction of Seminar]

1) Introduction to Morinaga Milk Industry’s Human-Residential Bifidobacteria (HRB)

2) Clinical Trials on Body Fat Reduction of B-3 (B.breve, Individually Approved Ingredient No. 2023-2)

3) Clinical Trials on Cognitive Function Improvement of B-3 (B.breve, Individually Approved Ingredient No. 2023-2)

[Brief Introduction of Speaker]

Dr. Izen Ri​ is a Senior Research Associate in the Functional Food Ingredients Division at Morinaga Milk Industry Co., Ltd., Japan, and a member of the expert taskforce of the International Probiotics Association (IPA) China. He has over a decade of experience in probiotic research and has extensive expertise in both fundamental research and clinical trials on probiotics. His work focuses on elucidating the effect of probiotics and postbiotics on gut immunity, metabolic syndromes, and allergic responses in both adults and infants.​ 

[Brief Introduction of Seminar]

In this seminar, Newtree, a leader in Korea's health functional food industry, will introduce its exclusive, individually recognized ingredient: 'Fermented Rice Germ Powder.' Powered by its key active compound, GABA, this ingredient has recently secured additional recognition for 'skin health' alongside its proven efficacy in 'improving sleep quality.' It has firmly established itself as a powerful dual-functionality ingredient capable of addressing two major health concerns simultaneously. As consumer needs for sleep health and inner beauty converge in the domestic market, the value of safe, effective, and naturally derived premium ingredients is higher than ever. This session will highlight the scientific evidence behind its sleep and skin health benefits, showcase its distinct market competitiveness, and explore strategic partnership opportunities in the healthcare market.

[Brief Introduction of Speaker]

Majored in Food Engineering and has been in charge of technical sales for health functional food ingredients at Newtree since 2021.​ 

[Brief Introduction of Seminar]

This presentation explores the rapid growth of oral beauty and women's systemic wellness products across key APAC markets.

We will go through different sub-categories across life stages, and the consumer trends driving them.  

And we will examine how innovative nurtrition supplement formats  combined with emerging ingredients, are reshaping what modern women expect from daily nutrition.

[Brief Introduction of Speaker]

Even Zhang has over 15 years of marketing experience across global, regional, and China markets, with 7+ years dedicated to the nutrition and wellness sector. She currently leads APAC product solutions at Sirio Pharma, driving triple-digit YoY sales growth in Q1 2026.

With deep expertise in consumer insights, product innovation, and go-to-market strategy,  Even brings a combination of strategic foresight and hands-on execution to the APAC wellness space.​